Schizophrenia
DA and schizophrenia DA pathways: ________ ( (b); D2 receptor Mesocortical (c); ___ ______ ________ (a); D2 receptor __________ (d); D2 receptor
Mesolimbic D1 receptor Nigrostriatal Tuberoinfundibular
Neurotransmitter imbalances (dopamine, glutamate, serotonin) b. induction of some positive symptoms by _______ and ______ (these INCREASE dopamine release and block _______)
amphetamine cocaine reuptake
Evidence for SEROTONIN 1. "_______" neuroleptics block specific ______ receptors 2.induction of "______ ______" by serotonin _______ (LSD, psilocybin) 3. ______ in serotonin receptors in schizophrenics
atypical serotonin Positive symptoms agonists changes
Neurotransmitter imbalances (dopamine, glutamate, serotonin) 1. Evidence for dopamine a. "________" neuroleptic drugs ______ dopamine receptors i. generally neuroleptic drugs degree of dopamine block is correlated with ______ ______
classical BLOCK clinical efficacy
SCHIZOPHRENIA 1. disorders of thought form and content a._______ b.disorders of perception-________
delusions hallucinations
DA and schizophrenia Dominant hypothesis is that there is _______ of mesolimbic, nigrostriatal and tuberoinfundibular (subcortical) and hypofunction of _______
hyperfunction mesocortical
Evidence for GLUTAMATE 3. ______ glutamate release in schizos 4. ______ in glutamate receptors
reduced changes
SCHIZOPHRENIA 2. MOTOR symptoms a. stereotyped ______ movements b. _______
repetitive catatonia
Neurotransmitter imbalances (dopamine, glutamate, serotonin) c. increases in dopamine receptors, ______ i. density of ____ receptors higher in _______ schizophrenics ii. schizophrenics have _______ DOPAMINE receptor SENSITIVITY
sensitivity D2 (dopamine) untreated increased
How do changes in these 3 systems produce schizophrenia? -excess _____/_____ or reduced ______ tend to decrease this inhibition (opens the gate) -_______ activity in the thalamo-_______-thalamicloop= _______ -increasing _______ activity and "____ fragmentation?"
dopmaine serotonin glutamate endogenous cortical HALLUCINATION sensory ego
What are the NEUROTRANMITTER IMBALANCES in Schizophrenia?
Dopamine Glutamate Serotonin
Some risk factors ________ -_______: low birth weight, prematurity, hypoxia, viral infections -Male (respond more to DA, no estrogen?) -DRUG ABUSE ______ ______: isolation, low dominance Many of these genes relate to dopamine signaling or synaptic development
Environmental Obstetric Social Adversity
SCHIZOPHRENIA 3. EMOTIONAL symptoms a. ______ affect, _______ affect 4. ________ symptoms (excesses) (meaning like present, active) EXAMPLE: delusions, hallucinations, movements -also ______ symptoms (LOSSES) e.g. _____, flat affect, asociality
Flat inappropriate POSITIVE Negative apathy
In regards to Schizophrenia, which symptoms respond better to DRUG TREATMENT?
Positive Symptoms
Schizophrenia is a _____ disorder.
Psychotic
Evidence for GLUTAMATE 1. dopamine inhibits glutamate release 2. _____ which produces positive symptoms has no known ______ effects, but is a glutamate (NMDA) receptor _______
inhibits PCP dopamine antagonist
How do changes in these 3 systems produce schizophrenia? a. disruption of ________->cortical gating of sensory information? -the thalamus may serve to GATE ______ ______ to the CORTEX -the _______ output is _______ to the thalamus (closes the gate)
thalamo sensory info striatal inhibitory
